Regeneron Pharmaceuticals (REGN) Shares Outstanding (Diluted Average) (2010 - 2026)

Regeneron Pharmaceuticals' Shares Outstanding (Diluted Average) history runs 17 years deep, the most recent figure standing at $107.7 million for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) fell 3.15% year-over-year to $107.7 million; the TTM figure through Mar 2026 stood at $107.7 million (down 3.15% YoY), while the FY2025 annual figure was $108.6 million, down 5.65% from the prior year.
• Shares Outstanding (Diluted Average) was $107.7 million for Q1 2026 at Regeneron Pharmaceuticals, down from $108.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $115.6 million in Q3 2024 to a low of $107.7 million in Q1 2026.
• Historically, Shares Outstanding (Diluted Average) has averaged $112.7 million across 5 years, with a median of $113.7 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Diluted Average) increased 2.89% in 2022, then decreased 5.8% in 2025.
• A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $113.5 million in 2022, then rose by 0.18% to $113.7 million in 2023, then gained by 1.23% to $115.1 million in 2024, then declined by 5.65% to $108.6 million in 2025, then slipped by 0.83% to $107.7 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $107.7 million (Q1 2026), $108.6 million (Q4 2025), and $108.9 million (Q3 2025), per Business Quant data.